Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FPHAX vs IHE overlap: 40% of top holdings shared

Bottom line

How much do FPHAX and IHE overlap?

40% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 48.0% of FPHAX's assets and 58.7% of IHE's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

FPHAXIHE
Weight overlap (top 25)40%
Shared holdings6
Weight in shared holdings48.0%58.7%
Total positions5759
Expense ratio0.67%0.37%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings FPHAX and IHE have in common

Holding% of FPHAX% of IHEOverlap
ELI LILLY and CO28.78%22.25%22.25%
Viatris Inc5.45%4.22%4.22%
MERCK and CO INC4.74%4.55%4.55%
Elanco Animal Health Inc4.15%2.81%2.81%
JOHNSON and JOHNSON3.77%22.44%3.77%
Axsome Therapeutics Inc1.08%2.42%1.08%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FPHAX

  1. Gsk Plc — 8.17%
  2. Ucb Sa — 5.09%
  3. Roche Holding Ag — 4.54%
  4. Legend Biotech Corp — 4.53%
  5. Astrazeneca Plc — 4.22%
  6. Jazz Pharmaceuticals Plc — 4.09%
  7. Gilead Sciences Inc — 3.97%
  8. Royalty Pharma Plc — 2.67%
  9. Fidelity Revere Street Trust — 2.44%
  10. Moderna Inc — 1.57%
  11. Intellia Therapeutics Inc — 1.19%
  12. Beam Therapeutics Inc — 1.10%
  13. Biontech Se — 1.04%
  14. Xenon Pharmaceuticals Inc — 0.82%
  15. Ocular Therapeutix Inc — 0.80%

Only in IHE

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  2. Bristol-myers Squibb Company — 4.37%
  3. Royalty Pharma Plc — 4.34%
  4. Pfizer Inc. — 3.96%
  5. Zoetis Inc. — 3.73%
  6. Jazz Pharmaceuticals Public Limited Company — 3.45%
  7. Corcept Therapeutics Incorporated — 1.90%
  8. Ligand Pharmaceuticals Incorporated — 1.45%
  9. Definium Therapeutics Inc — 1.39%
  10. Liquidia Corp — 1.28%
  11. Indivior Pharmaceuticals, Inc. — 1.14%
  12. Crinetics Pharmaceuticals Inc — 0.90%
  13. Organon & Co. — 0.81%
  14. Edgewise Therapeutics Inc — 0.70%
  15. Amneal Pharmaceuticals, Inc. — 0.68%

Asset mix

Asset typeFPHAXIHE
Stocks98.7%99.9%
Cash & short-term funds2.6%6.3%
Preferred stock0.7%—
Bonds0.1%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryFPHAXIHE
US64.8%96.4%
GB15.1%4.3%
BE5.3%—
CH4.5%—
KY4.5%0.2%
IE4.1%3.8%
CA1.1%1.4%
DE1.0%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FPHAX and IHE overlap?
About 40% by weight. 6 securities appear in both funds' top 25 holdings; they make up 48.0% of FPHAX's assets and 58.7% of IHE's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FPHAX and IHE have in common?
The largest shared holdings are ELI LILLY and CO, MERCK and CO INC, Viatris Inc, JOHNSON and JOHNSON, Elanco Animal Health Inc.
Should I own both FPHAX and IHE?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FPHAX or IHE?
IHE is broader, with 59 positions versus 57 for FPHAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.